e2-Capital, a recently formed online investment bank specializing in technology, media and telecommunications, plans to expand into healthcare and biotechnology in a bid to tap the growing market for herbal medicine and improved pharmaceuticals.
The bank û co-founded earlier this year by SJ Wong, former managing director and head of equity capital markets at BNP Prime Peregrine û has hired HM Pang to head up the company's biotechnology advisory group. Pang was previously executive director of Asia Healthcare and before that worked for several big pharmaceuticals companies including SmithKline Beecham, Glaxo and Norton.
e2-Capital circumvented the need for an initial public offering by agreeing...
